SCHD underperformed the S&P 500 in 2025 but remains highly attractive due to its strong risk-reward profile and dividend ...

Pfizer (PFE) ended the recent trading session at $25.35, demonstrating a -1.17% change from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily gain of 0.14%.

Council of the Americas, with the support of Pfizer, convenes high-level roundtable discussions across Latin America.

This was the stock's second consecutive day of losses.

International companies are increasingly inking licensing deals with China biotechs as concerns regarding drug pricing and ...

After resolving a patent dispute with Incyte, Sun Pharma has officially launched its JAK inhibitor Leqselvi in the U.S. | Sun ...

The attorney general is purging the Justice Department of employees connected to the Jan. 6 prosecutions, and the ...

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

Hearst has seen improvements in addressability between 30% and 200% since introducing AURA, its AI-powered ad targeting solution, last year.

Most of America was blissfully unaware of the havoc wreaked by urban renewal until Kelo, when the veil was lifted. Anybody’s ...

In 2008, the largest automotive recall in history occurred when Takata Corp. air bags in several brands of cars were found to ...

Pfizer Inc. (NYSE: PFE) is one of the 13 Best Large Cap Stocks to Buy Right Now. On July 10, Pfizer Inc. (NYSE:PFE) shared ...